Collegium Pharmaceutical, Inc. COLL Return on assets
Return on assets at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s return on assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s return on assets?
- Collegium Pharmaceutical, Inc. (COLL) reported return on assets of 4.6% in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s return on assets changed year-over-year?
- Collegium Pharmaceutical, Inc.'s return on assets increased by 42.8% year-over-year, from 3.2% to 4.6%.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s return on assets?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s return on assets has grown at a -7.6% compound annual growth rate (CAGR), from 5.6% to 3.8%.
- What does return on assets mean?
- Trailing-twelve-month net income divided by average total assets. Measures how efficiently the asset base generates profit, independent of how those assets are financed. Computed as net income over average total assets — note this is OpenCapital's standard definition and may differ from data vendors that use alternative numerators.